|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61P 3/10 | |||
| A61K 31/713 |
| (11) | Patento numeris | 3011026 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14813708.6 |
| Europos patento paraiškos padavimo data | 2014-06-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-04-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/043723 |
| Data | 2014-06-23 |
| (87) | Numeris | WO 2014/205449 |
| Data | 2014-12-24 |
| (30) | Numeris | Data | Šalis |
| 201361838211 P | 2013-06-21 | US |
| (72) |
CROOKE, Rosanne, M., US
ALEXANDER, Veronica, J., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | COMPOUNDS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION FOR IMPROVING A DIABETIC PROFILE |
| COMPOUNDS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION FOR IMPROVING A DIABETIC PROFILE |